JENNA V. CANZONIERO, M.D., M.S. | ASSISTANT PROFESSOR, BREAST & GYNECOLOGICAL MALIGNANCIES GROUP | JOHNS HOPKINS SIDNEY KIMMEL CANCER CENTER

Dr. Jenna Canzoniero will discuss newly approved oral drugs and indications for the treatment of breast cancer.  We will also highlight some exciting emerging oral drug development.  Finally we will discuss the role of tumor genetic analysis to guide use of these treatments.

To register, visit:

https://us02web.zoom.us/webinar/register/WN_Syem8IG7TliDrXP5JJE_oQ